U.S. Food and Drug Administration Approves Vuity (pilocarpine hydrochloride 1.25% ophthalmic solution) the first and only eye drop to treat presbyopia (age related blurry near vision)

AbbVie

29 October 2021 - Presbyopia, or age related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects, affecting most adults over the age 40.

Allergan today announced the U.S. FDA approval of Vuity (pilocarpine hydrochloride 1.25% ophthalmic solution) for the treatment of presbyopia, commonly known as age related blurry near vision, in adults.

Read AbbVie press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US